Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Knowing where to buy affordable basics ensures you get quality at a fair price. This guide points to reliable shops and budgeting tips for staples.
9,908 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
In March, following Buffett’s long-term approach, consider two stalwart names with durable moats and steady cash flow...
When a growth stock down nearly 50% from its high looks tempting, it helps to separate hype from fundamentals. This g...
If you’re weighing bond ETFs, VWOB and BND offer very different paths to fixed income. This guide breaks down costs, ...
Oil trades around the $100 barrel mark as investors seek safety. This piece identifies a top defensive ETF and explai...
Lockheed Martin has surged about 26% in 2026. Before you chase the rally, learn how to assess whether the stock still...
Fresh analyst calls are steering the early-week mood on Wall Street. Dell Technologies, BioMarin, Disney, HubSpot and...
A major portfolio move by Deepwater Asset Management shaved nearly half of its stake in Global-E Online. Here’s what ...
Poet Technologies stock sold off again as investors weigh dilution, growth prospects, and market jitters. This analys...
Two very different paths define the nuclear renaissance: NuScale's small modular reactors and BWX Technologies' broad...
American Superconductor surprised on the top line but traded lower as short-sellers reared their heads. This article ...
Cathie Wood of Ark Invest has sparked big talk about where crypto could go. This article outlines a practical approac...